scorecard

You Searched For "biontech stock price" and got 20 results


Sort By:


Business Insider Latest Story Image
1 min read

Moderna and BioNTech plummet more than 15% following news of Merck's COVID-19 antiviral pill

The antiviral drug could put a dent into the uptake of COVID-19 vaccines, as countries still strugg…

Matthew Fox   


Business Insider Latest Story Image
2 mins read

Pfizer and BioNTech surge after the FDA officially approves its COVID-19 vaccine

The vaccine will be marketed under the brand name Comirnaty, and the FDA hopes the approval will nu…

Matthew Fox   


Business Insider Latest Story Image
2 mins read

Moderna, BioNTech tumble 19% amid report the EU is looking into COVID vaccine side effects

The EU's drug regulator is looking at reports about skin rash and kidney problems.

Carla Mozée   


Business Insider Latest Story Image
1 min read

BioNTech soars after COVID-19 vaccine drives monster earnings beat and stronger guidance

BioNTech saw a more than 7,000% jump in revenue year-over-year from €27 million to €2 billion, driv…

Matthew Fox   


Business Insider Latest Story Image
1 min read

Moderna and BioNTech stocks are surging amid reports of FDA vaccine-approval progress

Moderna and BioNTech have climbed in recent weeks as the resurgent Delta variant has captured headl…

Ethan Wu   


Business Insider Latest Story Image
1 min read

BioNTech rallies 16% after boosting the sales forecast for its COVID-19 vaccine and projecting sturdy demand ahead

Vaccine demand is likely to persist well into next year, the company said, with more than a billion…

Ethan Wu   


Business Insider Latest Story Image
2 mins read

Pfizer and BioNTech climb as 95% vaccine effectiveness tees up application for FDA approval

The companies aim to apply for emergency-use authorization within days. If approved, the vaccine co…

Ben Winck   


Business Insider Latest Story Image
1 min read

BioNTech soars 7% after its vaccine appears to work against new variants of COVID-19

"So we've now tested 16 different mutations, and none of them have really had any significant impac…

Matthew Fox   


Business Insider Latest Story Image
1 min read

Pfizer, BioNTech gain after saying they'll submit their COVID-19 vaccine to the FDA for emergency approval

The companies "believe in their capability to distribute the vaccine globally upon approval or auth…

Matthew Fox   


Business Insider Latest Story Image
1 min read

Nearly 36,000 Robinhood users added Pfizer shares Wednesday after the US government ordered 100 million doses of its coronavirus vaccine

Pfizer is the most-added stock on Robinhood in the last 24 hours, according to data from Robintrack…

Carmen Reinicke   


Business Insider Latest Story Image
1 min read

Pfizer, BioNTech surge after the US government orders 100 million doses of COVID-19 vaccine

Adding the vaccine "increases the odds that we will have a safe, effective vaccine as soon as the e…

Carmen Reinicke   


Business Insider Latest Story Image
1 min read

Pfizer and BioNTech shares rise after FDA grants 2 coronavirus vaccines 'fast track' status

The candidates that received fast track status are the most advanced of four potential vaccines bei…

Carmen Reinicke   


Business Insider Latest Story Image
2 mins read

Moderna, BioNTech plunge as Bernie Sanders slams 'obscene' profits and tells drug makers to share COVID-19 vaccines with the world

"It's time for these pharmaceutical companies to share their vaccines with the world and start cont…

Matthew Fox   


Business Insider Latest Story Image
1 min read

Pandemic-related stocks from Zoom to Moderna jump as new coronavirus variant raises alarms and triggers lockdowns

The stock prices of vaccine makers Moderna and Pfizer surged Friday along with stay-at-home stocks …

Isabelle Lee   


Business Insider Latest Story Image
2 mins read

The billionaire scientist who developed Pfizer's breakthrough vaccine has not sold any shares in partner BioNTech's surging stock

Sahin and his wife, Ozlem Tureci, are the "dream team" couple whose company partnered with Pfizer t…

Shalini Nagarajan   


Business Insider Latest Story Image
1 min read

Moderna and Pfizer rebound after FDA authorizes third COVID-19 booster shot for immunocompromised

Year-to-date, shares of BioNTech, Moderna, and Pfizer have surged 357%, 275%, and 28%, respectively.

Matthew Fox   


Business Insider Latest Story Image
1 min read

Pfizer extends 5-day gain to record territory as US recommends COVID-19 booster shot

Pfizer cleared a massive resistance level last week when it surged above its record high of $47.39 …

Matthew Fox   


Business Insider Latest Story Image
2 mins read

'From unreasonable to ridiculous': Here's why Moderna is set to fall 76%, according to Bank of America

"To justify $200 billion in value, one has to assume 1 to 1.5 billion doses of COVID-19 vaccine eac…

Matthew Fox   


Business Insider Latest Story Image
1 min read

Pfizer jumps 6% to eclipse record high reached in 1999 as strength from COVID-19 vaccine continues

Shares of Pfizer jumped to a high of $48.57 on Tuesday, more than a dollar higher than its previous…

Matthew Fox   


Business Insider Latest Story Image
2 mins read

Moderna spikes 19% amid a flood of encouraging vaccine news, surpassing Merck in market value

Moderna, the almost 11 year old company that created a 95% effective pandemic ending vaccine in les…

Matthew Fox